<p>Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway</p>

Weili Xue(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Soochow University)
OncoTargets and Therapy
March 1, 2019
10.2147/ott.s187280
Cited by 31

Related Papers

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|246
ANGPTL8 negatively regulates NF-κB activation by facilitating selective autophagic degradation of IKKγ
|Nature Communications|2017|110
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
|Journal of Hematology & Oncology|2020|50
Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
|Nature Communications|2019|34
ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells <i>in vitro</i>
|Oncotarget|2015|24